have faith

Every snippet of info we have has indicated that the 48 week data will be impressive.

One day it will be reported that avx's drug is the best aid's drug in the world, which is what the data is suggesting atm. Sure, one can say that there are not many people in the trial, but they are ALL showing significant improvement.

Ethically it will be hard to justify avx's drug not being used as first line of therapy, as its benefits and safety profile are so significant. Hence, avx could be sitting on a billion dollar drug.

buy & hold, imho.